Kidney transplantation (KT) is the optimal therapy for end-stage kidney disease (ESKD),
resulting in significant improvement in survival as well as quality of life when compared with …

The long-term management of maintenance immunosuppression in kidney transplant
recipients remains complex. The vast majority of patients are treated with the calcineurin …

Advances in maintenance immunosuppression over the past three decades have improved
solid organ transplantation outcomes dramatically. Uninterrupted access to …

Post‐transplant diabetes mellitus (PTDM) shows a relationship with risk factors including
obesity and tacrolimus‐based immunosuppression, which decreases pancreatic insulin …

Abstract Background and objective The European Association of Urology (EAU) Panel on
Renal Transplantation released an updated version of the renal transplantation (RT) …

Deep learning consistently demonstrates high performance in classifying and segmenting
medical images like CT, PET, and MRI. However, compared to these kinds of images, whole …

Post-transplantation diabetes mellitus (PTDM) may severely impact both short-and long-term
outcomes of kidney transplant recipients in terms of graft and patient survival. However …

Background. Kidney transplant recipients have higher risk of infectious diseases due to their
reliance on immunosuppression. During the current COVID-19 pandemic, some clinicians …

Currently, kidney transplantation is the best treatment option for kidney failure for a majority
of eligible patients. It is associated with a better quality of life and reduced mortality as …

Simultaneous calcineurin inhibitor avoidance (CNIA) and early corticosteroid withdrawal
(ESW) have not been achieved primarily due to excessive acute rejection. This trial …